These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14292737)

  • 1. LABORATORY STUDIES ON THE REPOSITORY ANTIMALARIAL ACTIVITY OF 4,4'-DIACETYLAMINODIPHENYLSULFONE, ALONE AND MIXED WITH CYCLOGUANIL PAMOATE (CI-501).
    THOMPSON PE; OLSZEWSKI B; WAITZ JA
    Am J Trop Med Hyg; 1965 May; 14():343-53. PubMed ID: 14292737
    [No Abstract]   [Full Text] [Related]  

  • 2. Ex vivo antimalarial activity of proguanil combined with dapsone against cycloguanil-resistant Plasmodium falciparum isolates.
    Edstein MD; Yeo AE; Shanks GD; Rieckmann KH
    Acta Trop; 1997 Sep; 66(3):127-35. PubMed ID: 9210963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LABORATORY STUDIES ON 4,6DIAMINO-1-(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE PAMOATE (CI-501) AS A REPOSITORY ANTIMALARIAL DRUG.
    THOMPSON PE; OLSZEWSKI BJ; ELSLAGER EF; WORTH DF
    Am J Trop Med Hyg; 1963 Jul; 12():481-93. PubMed ID: 14044758
    [No Abstract]   [Full Text] [Related]  

  • 4. The repository antimalarial activities of 4,4'-diacetylaminodiphenylsulfone and cycloguanil pamoate (Cl-501) in monkeys relative to local release following parenteral administration.
    Thompson PE; Waitz JA; Olszewski B
    J Parasitol; 1965 Jun; 51(3):345-9. PubMed ID: 4953989
    [No Abstract]   [Full Text] [Related]  

  • 5. A statistical analysis of the antimalarial activity of proguanil and cycloguanil in human volunteers.
    Yeo AE; Edstein MD; Shanks GD; Rieckmann KH
    Ann Trop Med Parasitol; 1994 Dec; 88(6):587-94. PubMed ID: 7893172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of respository preparations of cycloguanil pamoate and 4,4'-diacetyldiaminodiphenylsulfone, alone and in combination, against infections with Plasmodium cynomolgi in rhesus monkeys.
    Schmidt LH; Rossan RN
    Antimicrob Agents Chemother; 1984 Nov; 26(5):611-42. PubMed ID: 6393864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYCLOGUANIL PAMOATE (CI-501) AS A CAUSAL PROPHYLACTIC AGAINST A SOUTHERN RHODESIAN STRAIN OF FALCIPARUM MALARIA.
    LUNN JS; CHIN W; CONTACOS PG; COATNEY GR
    Am J Trop Med Hyg; 1964 Nov; 13():783-5. PubMed ID: 14222428
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of CI-564, A 1:1 mixture of cycloguanil pamoate (CI-501) and 4,4'-diacetylaminodiphenylsulfone (CI-556), against multiresistant falciparum malarias.
    Chin W; Contacos PG; Coatney GR; Jeter MH; Alpert E
    Am J Trop Med Hyg; 1967 Sep; 16(5):580-4. PubMed ID: 4861322
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil.
    Kaneko A; Bergqvist Y; Takechi M; Kalkoa M; Kaneko O; Kobayakawa T; Ishizaki T; Björkman A
    J Infect Dis; 1999 Apr; 179(4):974-9. PubMed ID: 10068594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand.
    Wilairatana P; Kyle DE; Looareesuwan S; Chinwongprom K; Amradee S; White NJ; Watkins WM
    Ann Trop Med Parasitol; 1997 Mar; 91(2):125-32. PubMed ID: 9307653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro sensitivity of Plasmodium falciparum isolates from Gabon to chloroquine and cycloguanil].
    Pradines B; Mabika Mamfoumbi M; Keundjian A; Lebeau C; Fusai T; Owono Medang M; Rogier C; Parzy D; Kombila M
    Bull Soc Pathol Exot; 1999 May; 92(2):91-4. PubMed ID: 10399596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OCT1 Deficiency Affects Hepatocellular Concentrations and Pharmacokinetics of Cycloguanil, the Active Metabolite of the Antimalarial Drug Proguanil.
    Matthaei J; Seitz T; Jensen O; Tann A; Prukop T; Tadjerpisheh S; Brockmöller J; Tzvetkov MV
    Clin Pharmacol Ther; 2019 Jan; 105(1):190-200. PubMed ID: 29882324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE ACTIVITY OF A REPOSITORY FORM OF 4,6-DIAMINO-1(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE AGAINST INFECTIONS WITH PLASMODIUM CYNOMOLGI.
    SCHMIDT LH; ROSSAN RN; FISHER KF
    Am J Trop Med Hyg; 1963 Jul; 12():494-503. PubMed ID: 14044759
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-acting, repository antimalarial agents. Duration of protection in mice and monkeys following administration of pyrimethamine pamoate.
    Werbel LM; Jacobs RL; Steinkampf RW; Worth DF
    Am J Trop Med Hyg; 1984 Jul; 33(4):526-33. PubMed ID: 6236702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
    Krudsood S; Imwong M; Wilairatana P; Pukrittayakamee S; Nonprasert A; Snounou G; White NJ; Looareesuwan S
    Trans R Soc Trop Med Hyg; 2005 Feb; 99(2):142-9. PubMed ID: 15607340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans.
    Funck-Brentano C; Bosco O; Jacqz-Aigrain E; Keundjian A; Jaillon P
    Clin Pharmacol Ther; 1992 May; 51(5):507-12. PubMed ID: 1587064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the antimalarial effects of cycloguanil pamoate (CI-501) in man.
    Powell RD; DeGowin RL; Eppes RB
    Am J Trop Med Hyg; 1965 Nov; 14(6):913-21. PubMed ID: 5320454
    [No Abstract]   [Full Text] [Related]  

  • 18. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
    Pudney M; Gutteridge W; Zeman A; Dickins M; Woolley JL
    J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple-dose kinetics in healthy volunteers and in vitro antimalarial activity of proguanil plus dapsone.
    Edstein MD; Veenendaal JR; Rieckmann KH
    Chemotherapy; 1990; 36(3):169-76. PubMed ID: 2186899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemotherapy of rodent malaria. LXII. Drug combinations to impede the selection of drug resistance, part 5: rates of development of resistance to some inhibitors of folate metabolism and to artesunate.
    Stewart LB; Peters W; Robinson BL
    Ann Trop Med Parasitol; 2004 Dec; 98(8):763-83. PubMed ID: 15667710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.